![Dan Teleman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dan Teleman
Keine laufenden Positionen mehr
Vermögen: 113 268 $ am 30.09.2026
Profil
Dan Teleman was the founder of PRF Technologies Ltd., founded in 2007, and served as Chief Executive Officer from 2007 to 2010.
Former jobs include Chief Executive Officer at Atox Bio Ltd. from 2011 to 2022, Chief Executive Officer at Pharma Two B Ltd. from 2023 to 2025, Chief Executive Officer & Director at Nasus Pharma Ltd. from 2025 to 2026, Chairman at Tamarix Pharma Ltd from 2021 to 2023, Head-Marketing & Sales at Amgen, Inc., Senior Business Development Officer at W World Corp., Principal at Israel Defense Forces, and Executive Partner at Israel Biotech Fund from 2022 to 2023.
Education includes graduate studies at Ben-Gurion University of the Negev and an MBA from The Fuqua School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NASUS PHARMA LTD. 0,26 % | 17.06.2026 | 30 696 ( 0,26 % ) | 113 268 $ | 30.09.2026 |
Ehemalige bekannte Positionen von Dan Teleman
| Unternehmen | Position | Ende |
|---|---|---|
| NASUS PHARMA LTD. | Vorstandsvorsitzender | 22.07.2026 |
Pharma Two B Ltd.
 Pharma Two B Ltd. Pharmaceuticals: MajorHealth Technology Develops combination drugs for neurological disorders | Vorstandsvorsitzender | 01.01.2025 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01.05.2023 |
Tamarix Pharma Ltd
 Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Develops a novel small compounds for reducing excessive apoptosis | Vorsitzender | 01.05.2023 |
Atox Bio Ltd.
 Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Vorstandsvorsitzender | 01.05.2022 |
Ausbildung von Dan Teleman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
W World Corp.
 W World Corp. Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceutical products | Health Technology |
Ben-Gurion University of the Negev
 Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Israel Defense Forces
 Israel Defense Forces SovereignGovernment National security | Government |
PainReform Ltd.
 PainReform Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceuticals for pain treatment | Health Technology |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Health Technology |
Pharma Two B Ltd.
Pharma Two B Ltd. Pharmaceuticals: MajorHealth Technology Develops combination drugs for neurological disorders | Health Technology |
The Fuqua School of Business
 The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Nasus Pharma Ltd.
 Nasus Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops powder-based intranasal products | Health Technology |
Tamarix Pharma Ltd
Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Develops a novel small compounds for reducing excessive apoptosis | Health Technology |
